Helex selected to present a poster on a lipid nanoparticle-driven, gene editing-based therapeutic to address PKD1-driven ADPKD at ASN Kidney Week, Houston, Texas, November 6–9, 2025

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.